Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction.

[1]  Helena Antić,et al.  Myocardial tissue characterization by magnetic resonance imaging , 2017 .

[2]  C. Giannattasio,et al.  [Catecholamine-induced myocarditis in pheochromocytoma]. , 2017, Giornale italiano di cardiologia.

[3]  P. Matthews,et al.  Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.

[4]  C. Halsey,et al.  Pathologic and Cardiovascular Characterization of Pheochromocytoma-Associated Cardiomyopathy in Dogs , 2014, Veterinary pathology.

[5]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[6]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[7]  H. Timmers,et al.  Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? , 2013, The Journal of clinical endocrinology and metabolism.

[8]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[9]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[10]  T. Zelinka,et al.  High Incidence of Cardiovascular Complications in Pheochromocytoma , 2012, Hormone and Metabolic Research.

[11]  N. Nissen,et al.  Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  P. Dabadghao,et al.  Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study. , 2011, Surgery.

[13]  J. Lenders,et al.  Cardiovascular manifestations of phaeochromocytoma , 2011, Journal of hypertension.

[14]  Sung Kyun Shin,et al.  Prevalence and Patterns of Left Ventricular Dysfunction in Patients with Pheochromocytoma , 2011, Journal of cardiovascular ultrasound.

[15]  C. Bucciarelli-Ducci,et al.  Adrenergic Myocarditis in Pheochromocytoma , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[16]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[17]  A. Antonelli,et al.  Cardiovascular complications in patients with pheochromocytoma: a mini-review. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  V. Mai,et al.  Catecholamine-induced cardiomyopathy. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[19]  G. Bernini,et al.  Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter , 2008, Clinical endocrinology.

[20]  T. Zelinka,et al.  Characteristics of Blood Pressure in Pheochromocytoma , 2006, Annals of the New York Academy of Sciences.

[21]  T. Zelinka,et al.  Diurnal blood pressure variationin pheochromocytoma, primary aldosteronism and Cushing's syndrome , 2004, Journal of Human Hypertension.

[22]  B. Strauer,et al.  Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients , 1996, Journal of hypertension.

[23]  G. Chatellier,et al.  Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. , 1993, American journal of hypertension.

[24]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[25]  F. Fouad-Tarazi,et al.  Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines. , 1992, American journal of hypertension.

[26]  H. Zimmer,et al.  Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. , 1989, Circulation research.

[27]  A. Tajik,et al.  Echocardiographic findings in pheochromocytoma. , 1986, The American journal of cardiology.

[28]  R. S. Eliot,et al.  Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. , 1985, Journal of molecular and cellular cardiology.

[29]  L. Kurland,et al.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. , 1983, Mayo Clinic proceedings.

[30]  P. Simpson.  Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. , 1983, The Journal of clinical investigation.

[31]  N. Dhalla,et al.  Role of free radicals in catecholamine-induced cardiomyopathy. , 1982, Canadian journal of physiology and pharmacology.

[32]  H. Burchell,et al.  Focal myocarditis associated with pheochromocytoma. , 1966, The New England journal of medicine.

[33]  I. Kline.  Myocardial alterations associated with pheochromocytomas. , 1961, The American journal of pathology.

[34]  B. Mehlman,et al.  Pathologic changes induced by 1-norepinephrine , 1960 .

[35]  B. Mehlman,et al.  Pathologic changes induced by 1-norepineprine: quantitative aspects. , 1960, The American journal of cardiology.

[36]  J. E. Szakacs,et al.  L-Norepinephrine myocarditis. , 1958, American journal of clinical pathology.

[37]  R. M. Pearce.  EXPERIMENTAL MYOCARDITIS; A STUDY OF THE HISTOLOGICAL CHANGES FOLLOWING INTRAVENOUS INJECTIONS OF ADRENALIN , 1904, The Journal of experimental medicine.